Beetroot juice to boost blood vessels, insulin sensitivity, and exercise in prediabetes on vs. off metformin
Official title: The Interaction Between Inorganic Nitrate Supplementation and Metformin on Exercise Capacity, Vascular Function, and Insulin Sensitivity in Individuals With Pre-Diabetes
Run by University of Virginia · NCT07131384 · Data updated 2026-11-12
In people with prediabetes, this study tests whether short-term inorganic nitrate from beetroot juice can improve blood vessel health, insulin sensitivity, and exercise capacity, and compares those already taking metformin with those who are not.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | University of Virginia Academic / other |
| Locations | 1 site (Charlottesville, Virginia) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | June 1, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | June 3, 2026 |
| Trial ID | NCT07131384 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-60 with prediabetes who are sedentary and either currently taking metformin or naïve to metformin.
✕Probably not a fit
Individuals outside the prediabetes range or those with significant kidney impairment, high BMI, or other exclusions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, double-blind cross-over study involving 24 adults with prediabetes. Participants will receive inorganic nitrate (beetroot juice) or nitrate-depleted placebo in alternating periods, and will be categorized as metformin users or metformin-naïve. The study will measure vascular function, VO2 peak, lactate threshold, glucose tolerance, and endurance during exercise. It aims to see if nitrate supplementation can enhance vascular and metabolic responses without adverse effects in this population.
Why it matters
Potential benefit: If successful, beetroot nitrate could offer a simple dietary approach to improve vascular health and insulin sensitivity in prediabetes.
How similar studies have gone: Prior work suggests nitrate supplementation can enhance vascular function, with this study extending to prediabetes and metformin status; the exact benefits in this context remain to be proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals who can communicate meaningfully with the investigator and can provide written consent. * Confirmed prediabetic individuals (ages 18-60 years old) (2-hour glucose of 140-199 mg/dL following OGTT test or HbA1c between 5.7-6.4% tested on two occasions within 6 months). * Taking metformin (stable dose for at least a week) or naïve to metformin * Sedentary (\<1 day/week of structured exercise) * Be able to perform exercise on a cycle ergometer without assistance * Stable medication regimen for the last 6 months * If female, have a normal menstrual cycle Exclusion Criteria: * Estimated Glomerular filtration rate (GFR) ≤ 45 * Body mass index ≥ 40 Kg/m2 * HbA1c \> 6.4% * Smokers within the last 5 years * Has experienced significant weight loss \~3 kg in the last three months or is taking any weight loss drugs * Current medical condition that prohibits exercising at high intensities * Currently on hormone replacement of any kind * History of myocardial infarction, cerebrovascular event, acute or unstable disease other than pre-diabetes or obesity * Currently taking any of the following medications (calcium channel blockers, statins, ACE or renin inhibitors, angiotensin receptor blockers, organic nitrates (e.g., nitroglycerine) or recent regular use of inorganic nitrates, alpha- or beta-blockers, diuretics, proton pump inhibitors, PDE-5 inhibitors (e.g.,: Cialis, Viagra), or xanthine oxidase inhibitors (e.g.,: Allopurinol)) * Oral antibiotic use within the previous four weeks, including over-the-counter antibacterial mouthwash or a mouthwash containing chlorhexidine and unwilling to discontinue use * Oral cancer/severe oral disease * Uncontrolled hypertension (\>140/90) * Had hysterectomy or oophorectomy * Fetuses, neonates, children, prisoners, cognitively impaired, non-English speaking participants
Where it's running
-
University of Virginia
Charlottesville, Virginia, United States Recruiting
Study contacts
- Principal investigator: Jason Allen, PhD — University of Virginia
- Study coordinator: Money Ghimire, M.S
- Email: eta8xd@uvahealth.org
- Phone: 4342438677
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Metformin to Improve Live Birth Rates in Women with Prediabetes Undergoing IVF
This study is testing if taking metformin before IVF can help women with prediabetes have a healthier chance of getting pregnant and having a baby.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Hourly stair-climbing snacks to improve blood sugar and heart health in adults with prediabetes
This study tests whether short stair-climbing bursts every hour can improve blood sugar and vascular health in adults with prediabetes.
-
Smart probiotic and nutraceutical approach for cardiometabolic health in older adults
This trial tests whether a probiotic-containing nutraceutical strategy can improve metabolic health and blood pressure in adults over 65 with prediabetes or cardiovascular disease.
-
Family-based diabetes prevention for parents and kids
A family-focused program tests whether a 12-week lifestyle plan can help parents at risk for diabetes lose weight and improve healthy habits for themselves and their children aged 12–17.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.